LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway

Carcinogenesis

Volumn 36, Issue 10, 2015, Pages 1201-1212

  Luo, Qin ^a   Wang, Cun ^a   Jin, Guangzhi ^b   Gu, Dishui ^a   Wang, Ning ^a   Song, Jin ^a   Jin, Haojie ^a   Hu, Fangyuan ^a   Zhang, Yurong ^a   Ge, Tianxiang ^a   Huo, Xisong ^a   Chu, Wei ^a   Shu, Huiqun ^a   Fang, Jingyuan ^a   Yao, Ming ^a   Gu, Jianren ^a   Cong, Wenming ^b   Qin, Wenxin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; JANUS KINASE 1; LEUKEMIA INHIBITORY FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; JAK1 PROTEIN, HUMAN; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA; LIFR PROTEIN, HUMAN; MMP13 PROTEIN, HUMAN; ONCOPROTEIN; TUMOR MARKER;

ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR INVASION; ADULT; AGED; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; PROGNOSIS;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JANUS KINASE 1; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; NEOPLASM METASTASIS; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 84943785018     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv108     Document Type: Article

References (32)

1. Singal, A.G. et al. (2014) Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med., 11, e1001624.
2. Bruix, J. et al. (2014) Hepatocellular carcinoma: clinical frontiers and perspectives. Gut, 63, 844-855.
3. Mierke, C.T. (2014) The fundamental role of mechanical properties in the progression of cancer disease and inflammation. Rep. Prog. Phys., 77, 076602.
4. Gearing, D.P. et al. (1991) Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J., 10, 2839-2848.
5. Kishimoto, T. et al. (1995) Interleukin-6 family of cytokines and gp130. Blood, 86, 1243-1254.
6. Tomida, M. (2000) Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells. Leuk. Lymphoma, 37, 517-525.
7. Chen, D. et al. (2012) LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat. Med., 18, 1511-1517.
8. Hergovich, A. (2012) YAP-Hippo signalling downstream of leukemia inhibitory factor receptor: implications for breast cancer. Breast Cancer Res., 14, 326.
9. Blanchard, F. et al. (2003) DNA methylation controls the responsiveness of hepatoma cells to leukemia inhibitory factor. Hepatology, 38, 1516-1528.
10. Okamura, Y. et al. (2010) Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array. Cancer Lett., 289, 170-177.
11. Luo, Q., et al. (2015) Leukemia inhibitory factor receptor is a novel immunomarker in distinction of well-differentiated HCC from dysplastic nodules. Oncotarget, 6, 6989-6999.
12. Jin, G.Z. et al. (2013) SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma. J. Hepatol., 59, 510-517.
13. El-Serag, H.B. et al. (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-2576.
14. Bruix, J. et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol., 35, 421-430.
15. Jin, G.Z. et al. (2011) iTRAQ-2DLC-ESI-MS/MS based identification of a new set of immunohistochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma. J. Proteome Res., 10, 3418-3428.
16. Li, Y. et al. (2001) Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J. Gastroenterol., 7, 630-636.
17. Wurmbach, E. et al. (2007) Genome-wide molecular profiles of HCVinduced dysplasia and hepatocellular carcinoma. Hepatology, 45, 938-947.
18. Chen, X. et al. (2002) Gene expression patterns in human liver cancers. Mol. Biol. Cell, 13, 1929-1939.
19. Huang, F. et al. (2007) Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells. J. Immunol., 179, 6504-6513.
20. Lütticken, C. et al. (1994) Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science, 263, 89-92.
21. Stahl, N. et al. (1994) Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science, 263, 92-95.
22. Larue, L. et al. (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene, 24, 7443-7454.
23. Shoushtari, A.N. et al. (2011) Metastasis-suppressor genes in clinical practice: lost in translation? Nat. Rev. Clin. Oncol., 8, 333-342.
24. Welgus, H.G. et al. (1983) The collagen substrate specificity of rat uterus collagenase. J. Biol. Chem., 258, 14162-14165.
25. Kobayashi, K. et al. (2012) Oct-3/4 promotes migration and invasion of glioblastoma cells. J. Cell. Biochem., 113, 508-517.
26. Zhang, B. et al. (2008) Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer, 8, 83.
27. Easwaran, H. et al. (2014) Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol. Cell, 54, 716-727.
28. Wu, M.H. et al. (2012) Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways. J. Cell. Physiol., 227, 3016-3026.
29. Taga, T. et al. (1992) Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. USA, 89, 10998-11001.
30. Gearing, D.P. et al. (1992) The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science, 255, 1434-1437.
31. Guschin, D. et al. (1995) A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J., 14, 1421-1429.
32. Rane, S.G. et al. (2000) Janus kinases: components of multiple signaling pathways. Oncogene, 19, 5662-5679.